Chronic hepatitis B virus infection persists because the virus uses multiple coordinated molecular strategies to blunt and evade host immunity. These mechanisms operate at the level of viral persistence, antigen presentation, and immune-cell function, producing long-term tolerance that underlies disease progression and treatment challenges. Maria Rehermann National Institutes of Health has characterized how impaired virus-specific T cell responses are central to persistence, framing many downstream consequences.
Viral persistence and antigenic burden
The viral minichromosome cccDNA in infected hepatocyte nuclei acts as a stable template for viral transcription, making complete viral elimination difficult. Ulrich Protzer Technical University of Munich has emphasized that cccDNA stability explains why antiviral nucleos(t)ide therapies suppress replication but rarely cure infection, because transcriptionally active reservoirs remain. Hepatitis B surface antigen HBsAg is produced in large excess as noninfectious subviral particles; this antigenic overload promotes immune tolerance by chronically stimulating and desensitizing antigen-specific lymphocytes. Hepatitis B e antigen HBeAg has additional tolerogenic effects during perinatal and early-life exposure, contributing to the high chronicity seen in some populations.Disruption of innate sensing and antigen presentation
HBV proteins interfere with pattern-recognition and interferon signaling pathways. The regulatory HBx protein and polymerase can modulate signaling adaptors and transcription factors that drive interferon responses, reducing early innate control and lowering activation cues for adaptive immunity. Dampened innate signaling reduces dendritic cell maturation and antigen presentation, so T cells receive weaker costimulatory signals and fail to fully differentiate into effective effectors.Adaptive immune exhaustion and regulatory networks
Chronic antigen exposure drives T cell exhaustion characterized by expression of inhibitory receptors such as PD-1 and CTLA-4, metabolic dysregulation, and loss of proliferative capacity. Antonio Bertoletti Duke-NUS Medical School has described how exhausted CD8 and CD4 T cells in chronic hepatitis B show impaired cytokine production and cytotoxicity, limiting viral clearance. Regulatory T cells and immunosuppressive cytokines further suppress antiviral responses, while viral mutations in key epitopes allow escape from remaining neutralizing antibodies and T cell recognition.These molecular mechanisms have human, cultural, and territorial relevance: regions with high perinatal transmission see more immune tolerance and chronic carriage, affecting public-health strategies. Environmentally, persistent immune evasion increases long-term risk of fibrosis and hepatocellular carcinoma, shaping surveillance and treatment priorities. Understanding these pathways guides therapeutic research aimed at reducing cccDNA activity, restoring innate sensing, and reversing T cell exhaustion to achieve functional cure.